Alcresta Pharmaceuticals Inc.
Enyzme products for gastrointestinal and rare diseases
This article was originally published in Start Up
Alcresta Pharmaceuticals Inc. aims to combat malabsorption, with an initial focus on enzyme deficiencies, for people with gastrointestinal disorders and rare diseases. It is developing a pipeline of point-of-care nutritional products tailored to maximize the absorption of calories or specific nutrients, based on cartridges enclosing enzymes immobilized onto polymer beads.
Register for our free email digests: